Breaking News
Get 50% Off 0
🚀 June’s AI-picked stocks soar, with Adobe +18.1% in 11 days. Don’t miss July’s upcoming picks. Unlock full list
Close

Pfizer Inc. DRC (PFEm)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8,850.00 +155.00    +1.78%
03:59:00 - Closed. Currency in ARS ( Disclaimer )
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT111424 
  • Volume: 5,282
  • Bid/Ask: 8,850.00 / 8,890.00
  • Day's Range: 8,524.50 - 9,253.00
Pfizer DRC 8,850.00 +155.00 +1.78%

PFEm Income Statement

 
Featured here, the Income Statement (earnings report) for Pfizer Inc. DRC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Income Statement
Period Ending: 2024
31/03
2023
31/12
2023
01/10
2023
02/07
Total Revenue 14878 14249 13232 12734
Revenue 14878 14249 13232 12734
Other Revenue, Total - - - -
Cost of Revenue, Total 3036 13114 3305 2932
Gross Profit 11842 1135 9927 9802
Total Operating Expenses 10188 21369 10278 10077
Selling/General/Admin. Expenses, Total 3348 4114 3112 3332
Research & Development 2480 2874 2682 2629
Depreciation / Amortization 424 399 - 384
Interest Expense (Income) - Net Operating -790 -688 -695 -508
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 1674 1556 1874 1308
Operating Income 4706 -7120 2954 2657
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 175 2299 -171 130
Other, Net 1110 -5290 6477 258
Net Income Before Taxes 3421 -4129 -3352 2269
Provision for Income Taxes 293 -795 -964 -71
Net Income After Taxes 3128 -3334 -2388 2340
Minority Interest 276 274 270 274
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 3120 -3343 -2394 2329
Total Extraordinary Items -5 -26 12 -2
Net Income 3115 -3369 -2382 2327
Total Adjustments to Net Income 5 26 -12 2
Income Available to Common Excluding Extraordinary Items 3120 -3343 -2394 2329
Dilution Adjustment -18.35 4.11 -10.68 -15.33
Diluted Net Income 3133.35 -3373.11 -2371.32 2342.33
Diluted Weighted Average Shares 5697 5647 5646 5713
Diluted EPS Excluding Extraordinary Items 0.55 -0.597 -0.424 0.41
DPS - Common Stock Primary Issue 0.42 0.41 0.41 0.41
Diluted Normalized EPS 0.445 -0.726 0.351 0.336
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFEm Comments

Write your thoughts about Pfizer Inc. DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email